NCT00488592 2021-07-12Peptide Vaccinations to Treat Patients With Low-Risk Myeloid CancersNational Institutes of Health Clinical Center (CC)Phase 2 Completed10 enrolled 7 charts
NCT00004918 2013-01-07Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic SyndromeNational Cancer Institute (NCI)Phase 1/2 Completed69 enrolled